Background
Ischemic heart disease is the leading cause of death globally, causing approximately 9 million deaths annually. Currently, reperfusion therapy (such as thrombolysis or interventional procedures) is the primary method to…
Advances in nanomaterials revolutionize therapy for myocardial ischemia-reperfusion injury
